Evidence map›Paper›PMID 40181274›Full record

ArticleBMC infectious diseases2025

Central line-associated bloodstream infections (CLABSI) in critical care: understanding incidence, and risk factors in Palestine.

Sameer Alomari, Mohammad Yahya, Nadeem Alabadlah, Khader Thiab, Walid Basha, Haneen Dhaidel, Razan Rabi, Dina Abugaber, Ahmad Enaya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sameer Alomari *Faculty of Medicine, an-Najah National University, Nablus, Palestine.
Mohammad Yahya *Faculty of Medicine, an-Najah National University, Nablus, Palestine.
Nadeem Alabadlah *Faculty of Medicine, an-Najah National University, Nablus, Palestine.
Khader Thiab *Faculty of Medicine, an-Najah National University, Nablus, Palestine.
Walid BashaDivision of Microbiology, Immunology, and Pathology, Department of Biomedical Sciences-Faculty of Medicine and Health Sciences-an-Najah National University, Nablus, Palestine.
Haneen DhaidelDepartment of Applied and Allied Medical Sciences, Faculty of Medicine and Health Sciences, an-Najah National University, Nablus, Palestine.
Razan RabiDepartment of Internal Medicine, An-Najah National University Hospital, Box 7,707, Nablus, Palestine.
Dina AbugaberDepartment of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Box 7,707, Nablus, Palestine. dina.abugaber@najah.edu.
Ahmad EnayaDepartment of Internal Medicine, An-Najah National University Hospital, Box 7,707, Nablus, Palestine. a.anaya@najah.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCentral line-associated bloodstream infections (CLABSIs) represent a major source of morbidity and mortality, particularly in developing countries. Central venous catheters (CVCs) are an essential part of managing critically ill patients. This study seeks to describe the epidemiology of central line-associated bloodstream infections CLABSI among ICU patients in Palestine and to identify the specific organism involved.

methodsThis retrospective descriptive study included 323 ICU patients with 490 central venous catheters. The electronic medical records were reviewed to identify patients with CLABSIs hospitalized from January 2018 through December 2021. Comparative analysis was conducted to assess associations between various variables and the incidence of CLABSI.

resultA total of 19 CLABSI episodes in 323 patients yielded an incidence of CLABSI of approximately 5.9%, with a rate of 8.91 per 1,000 device days. CLABSI patients had significantly more CVC utilization ratio and insertions compared to non-CLABSI patients. No significant differences were observed in age, gender, or overall mortality. The most predominant bacteria was Acinetobacter baumannii (21%).

conclusionThis study highlights the importance of minimizing CVC use and limiting the number of insertions to reduce CLABSI risk. Effective management strategies should focus on reducing CVC duration and frequency.

Indexed as

BacteremiaCatheterization, Central VenousCatheter-Related InfectionsCritical CareAdultAgedCentral Venous CathetersFemaleHumansIncidenceIntensive Care UnitsMaleMiddle AgedMiddle EastRetrospective StudiesRisk FactorsCentral line-associated bloodstream infectionsCentral venous catheters (CVC)Intensive care unit

Identifiers

PMID40181274
PMCPMC11970027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.